Article Information
History
- February 8, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- C Kedor1,*,#,
- H Freitag1,*,
- L Meyer-Arndt2,
- K Wittke1,
- T Zoller3,
- F Steinbeis3,
- M Haffke1,
- G Rudolf1,
- B Heidecker4,
- HD Volk1,5,
- C Skurk4,
- F Paul2,
- J Bellmann-Strobl2,* and
- C Scheibenbogen1,*
- 1Institute of Medical Immunology, 13353 Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin and Berlin Institute of Health, Germany
- 2Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin
- 3Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin
- 4Department of Cardiology, Charité - Universitätsmedizin Berlin
- 5Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité University Medicine Berlin, Germany
- ↵# Corresponding author; email: claudia.kedor{at}charite.de
Posted February 08, 2021.
Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS) following the first pandemic wave in Germany – a first analysis of a prospective observational study
